72.19.Z - Scientific research and development activities
2018 | 2019 | ||
---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss) | -12,8 | -90,3 | -607,2 |
EBITDA | -8,4 | -82,7 | -883,8 |
Short time liabilities | 2,6 | 7,8 | 198,1 |
Equity capital | 10,5 | -79,8 | -860,2 |
Operating profit (EBIT) | -8,4 | -82,7 | -883,8 |
Assets | 74,7 | 9,6 | -87,2 |
Net profit (loss) | -12,8 | -90,3 | -607,2 |
Cash | 4,3 | 2,4 | -44,3 |
Liabilities and provisions for liabilities | 64,2 | 89,4 | 39,2 |
Net income from sale | 0 | 0 | 0 |
Working assets | 13,3 | 9,6 | -28,3 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | -121,6 | 113,2 | 234,8 |
Equity capital to total assets | 14,1 | -835,4 | -849,5 |
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 5.095141410827637 | 1.225853681564331 | -3,9 |
Net dept to EBITDA | -6.817051887512207 | -0.957569420337677 | 5,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane